Eczema Research Study
Researchers at the University of Michigan are conducting a study on adults with atopic dermatitis (eczema) to understand it better, especially in different groups of people.
Fast Facts
Diagnosed with eczema
Currently taking Dupilumab (Dupixent) and still experiencing eczema symptoms
Compensation Provided
Conducted in Ann Arbor, MI
Study Background
Researchers at the University of Michigan are conducting a study on individuals with eczema that involves collecting blood and skin samples and information on skin inflammation.
Recent research has greatly improved our understanding of eczema and its treatment, yet much of this knowledge is based on studies involving Caucasian individuals, leaving a gap in understanding how eczema affects African Americans, Asians, and Hispanics.
Studies reveal that Asian, African American, and Hispanic populations are more prone to eczema than Caucasians, with African American children being nearly twice as likely to develop eczema even with similar socioeconomic factors.
Differences in certain genes have been observed among ethnic groups with eczema, suggesting varying immune responses. However, current research cannot pinpoint cellular-level changes and specific affected areas in the body, highlighting the need for advanced technology to gain a deeper understanding of eczema across different ethnicities.
Study Background
Researchers at the University of Michigan are conducting a study on individuals with eczema that involves collecting blood and skin samples and information on skin inflammation.
Recent research has greatly improved our understanding of eczema and its treatment, yet much of this knowledge is based on studies involving Caucasian individuals, leaving a gap in understanding how eczema affects African Americans, Asians, and Hispanics.
Studies reveal that Asian, African American, and Hispanic populations are more prone to eczema than Caucasians, with African American children being nearly twice as likely to develop eczema even with similar socioeconomic factors.
Differences in certain genes have been observed among ethnic groups with eczema, suggesting varying immune responses. However, current research cannot pinpoint cellular-level changes and specific affected areas in the body, highlighting the need for advanced technology to gain a deeper understanding of eczema across different ethnicities.
Additional Information
New research has helped us learn more about atopic dermatitis (eczema) and how to treat it, but most studies have mainly looked at Caucasians, leaving out a lot of information. Eczema affects Asian, African American, and Hispanic people more than others, showing that different groups may have different ways their bodies react to it. We need better technology to understand eczema better, especially in different groups of people.
You may qualify for a study if you meet the following criteria.
Inclusion Criteria:
- Diagnosed with atopic dermatitis (eczema)
- Have had eczema for at least 1 year
- Currently taking Dupilumab (Dupixent) and still experiencing eczema symptoms
- 18+ years old
- No current diagnosis of cancer
- No current diagnosis of other inflammatory skin conditions besides eczema/atopic dermatitis (acne is allowed)
- No history of keloids or blood-borne disease
- Not pregnant
Participants in this research study will attend one research visit lasting between 1.5 to 2 hours. During this visit, participants will complete surveys, participate in medical history interviews, undergo skin examinations, and provide samples of blood and skin biopsies. Additionally, participants will have the option to have their photographs taken. It is important to note that this study does not involve any medical treatments or interventions.
Participants who fully complete study visits may receive up to $190.
There is no cost for you to participate in our research study.